Beximco Pharmaceuticals Ltd Case Study

1. Introduction

1.1. Why we choose the tropic

Beximco pharmaceuticals Ltd (Beximco pharma) is a leading pharmaceutical company in Bangladesh. They are leading with various products and service. As it is a practical scenario of a company’s dividend policy we found Beximco pharma as a better option because they regularly published their annual report, audited report and they are the industry leader. So if we analyze on this company we think we will be able to understand what should be practical implication of dividend policy in a company.

1.2. Objective of the study

The core objective of this report is to illustrate the present policy of dividend in Beximco pharma. But there are some specific objective of this report also.

1.2.1. Specific objectives:

 To have a clear view about what is actually happening in the area of dividend policy in the selected business company

 To relate the theoretical knowledge with practical

 To have an analysis on Dividend policy of Beximco pharma

 Identify existence issues of Dividend policy and lack of process that will facilitate the proper practices of Dividend policy

1.3. Methodology

This is qualitative research as I had to collection information from different kinds of newspaper, annual report, and news from DSE (Dhaka Stock Exchange) to create the whole report. It presents study area, techniques of data collection, limitation and sources of data and so on. These are whole procedure of the research work.

1.3.1. Research design

As we mentioned earlier this report is a described one along with some information. This report mainly focus on the dividend policy on the selected company. This report contains an overview of Beximco pharmaceuticals Ltd, the financial performance of the organization and finally, the paid out dividends were analyzed in contrast to some other financial indicators and which type of dividend policy they followed.

1.3.2. Source of data

One types of data source we have used.

1.3.2.1. Secondary data

 Company Websites, Newspapers.

 Annual Reports

 Audited financial statements

 Dhaka Stock Exchange

1.3.3. Data collection

We discussed with experts who have vast knowledge about the dividend policy, organization and report making model

1.3.4. Data analysis

From the whole data and information we collected, we can assume some point from some prospection

1.3.5. Limitations of the study

 Some information required to prepare this report were not found in annual reports or websites.

 Though, there are available resources to know about the products of this company but no or very few written documents are available for the operating procedures. Hence a scarcity of secondary sources prevailed in this case.

 Published information is not up to date

 As the report has to be submitted within 15-20 days duration of the semester. Hence some parts are discussed very briefly.

1.3.6. Report preview:

I use direct writing style to make the report. Because maximum people will be able to understand the tropic if we maintain direct writing style. Normally reports used to written direct writing styles. We think if we make the report in direct writing style then it will be more successful communication that we want to do.

2. Report Body

2.1. About Organization:

BEXIMCO Pharmaceuticals Ltd. is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. It is the flagship company of BEXIMCO Group, the largest private sector industrial conglomerate in Bangladesh. It is acclaimed for its outstanding product quality, world-class manufacturing facilities, product development capabilities and outstanding professional services. BEXIMCO Pharma is the pioneer in pharmaceutical exports from Bangladesh and has received National Export Trophy (Gold), the highest national accolade for export, for record three times.

BEXIMCO Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA. It has now grown to become a leading pharmaceutical company in Bangladesh, and it supplies more than 10% of country's total medicinal needs. Today BEXIMCO Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. Number of Employees are 2310.

2.2. Mission Statement:

“Each of our activities must benefit and add value to the common wealth of our society”

2.3. Mission:

Beximco Pharmaceutical are committed to enhancing human health and wellbeing by providing contemporary and affordable medicines, manufactured in full compliance with global quality standards. They continually strive to improve their core capabilities to address the unmet medical needs of the patients and to deliver outstanding results for their shareholders.

2.4. Vision:

Beximco Pharmaceutical will be one of the most trusted, admired and successful pharmaceutical companies in the region with a focus on strengthening research and development capabilities, creating partnerships and building presence across the globe.

2.5. Core values:

Core values define who we are; they guide us to take decisions and help realize their individual and corporate aspirations.

 Commitment to quality: They adopt industry best practices in all their operations to ensure highest quality standards of their products.

 Customer